Topics

Ernest Bai Koroma
Ebola vaccine heads to Liberia for tests even as crisis eases
Ebola vaccine heads to Liberia for tests even as crisis eases

The first 300 doses of an experimental Ebola vaccine were headed for Liberia on Friday, but health authorities say the West African nation may already have turned the corner on slowing the outbreak of the deadly disease. Although the vaccine was developed to the testing stage at record speed by British pharmaceutical company GlaxoSmithKline, it probably comes too late to have a significant effect on turning around the outbreak of Ebola: The turning point may have already come. New infections in the three worst-hit countries are already declining sharply, according to statistics from the World Health Organization, and testing of the new vaccine in West Africa is still several weeks...

Loading